In general, tumor cells bring immune suppression in the TME through the programmed cell death protein 1 (PD-1)-mediated signaling pathway induced by its ligands, programmed death ligands 1 and 2 (PD-L1 and PD-L2) (100). This evidence concerns the gene CD274 and neoplasm.